Hospital-at-home care for exacerbations of chronic obstructive pulmonary disease: an observational cohort study of patients managed in hospital or by nurse practitioners in the community

Abstract

The Urgent Care Team (UCT) in Sunderland (pop. 293,000) is a unique nurse practitioner service operating a hospital at home 24/7/365 to deal promptly with patients suffering an exacerbation of their COPD (AECOPD). Treatment is according to patient group directions utilising nebulised bronchodilators, doxycycline and prednisolone. To compare the health status and pathophysiology during and two months after an AECOPD in 60 UCT patients (31 male) and 30 hospital-managed patients (16 male). The St. Georges Respiratory Questionnaire (SGRQ), Mahler Baseline Dyspnoea Index (BDI) and MRC dyspnoea score recorded health status. Spirometry, BMI and grip strength were also measured. All patients were reviewed 2–3 months after the AECOPD. Changes from BDI were measured using the Transitional Dyspnoea Index (TDI). Mean FEV₁% predicted was 47%. In the recovery phase the two groups were comparable for all variables. But during their AECOPD hospitalised patients had a significantly lower BDI (P < 0.05) and an oxygen saturation ranging from 84 to 93% compared with 87–96% for UCT patients. Paired t-tests indicated that on recovery SGRQ activity domain and TDI measures improved in both groups. No deaths occurred during these AECOPDs. A hospital-at-home scheme for AECOPDs can deal with patients who have severe COPD safely. The Mahler TDI appears to be a sensitive index of improvement after an AECOPD.

Keywords

chronic obstructive pulmonary disease exacerbations health-related quality of life hospital-at-home

References

1 Rabe KF Hurd S Anzeuto A Barnes PJ Buist SA Calverley P . Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 176: 532–555.

2 Wilkinson T Donaldson GC Hurst R Seemungal TAR . Early therapy improves outcomes of Exacerbations of Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 2000; 169: 1298–1303.

3 Cotton MM Bucknall CE Dagg KD Jhonson MK Mac Gregor G Stewart C . Early discharge for patients with exacerbations of COPD: a randomised controlled trial. Thorax 2000; 55: 902–906.

4 Gravil JH Al-Rawas OA Cotton MM Flanigan U Irwin A Stevenson RD . Home treatment of exacerbations of chronic obstructive pulmonary disease by an acute respiratory assessment service. Lancet 1998; 351: 1853–1855.

5 Ram FSF Wedzicha JA Wright J Greenstone M . Hospital at home for patients with acute exacerbations of chronic obstructive pulmonary disease: systematic review of evidence. Br Med J 2004; 329: 315–318.

6 Curry R . Vision to reality: using patients’ voice to develop and improve services. Br J Community Nurs 2006; 11: 438–445.

7 National Collaborating Centre for Chronic Conditions . Chronic obstructive pulmonary disease in adults in primary and secondary care. Thorax 2004; 59: S1–S232.

9 Sunnerhagen KS . Muscle performance in an urban population sample of 40- to 79-year-old men and women. Scand J Rehabil Med 2000; 32: 159–167.

10.

10 American Thoracic Society . Standardization of spirometry. Am J Respir Crit Care Med 1995; 152: 1107–1136.

11.

11 Standardized lung function testing. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 1–100.

12.

12 Fletcher CM . Standardised questionnaire on respiratory symptoms: a statement prepared and approved by the MRC Committee on the Aetiology of Chronic Bronchitis (MRC breathlessness score). Br Med J 1960; 2: 1665.

13.

13 Mahler DA Faryniarz K Tomlinson D Colice GL Robins AG . Impact of dyspnoea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. Chest 1992; 102: 395–401.

14.

14 Jones PW . Measurements of health in asthma and chronic obstructive airway disease. Pharma Med 1992; 6: 13–22.

15.

15 Jones PW . Issue concerning health related quality of life in COPD. Chest 1995; 107(Suppl. 5): 187S–193S.

16.

16 Charlson M Szatrowski T Peterson J Gold J . Validation of a combined comorbidity index. J Clinical Epidemiology 1994; 47: 1245–1251.

17.

17 Seemungal TAR Donaldson GC Bhowmik A Jefferies DJ Wedzicha JA . Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 161: 1608–1613.

18.

18 Aaron SD Vandemheen KL Clinch JJ Ahuja J Robert JB Dickinson G . Measurement of short term changes of dyspnoea and disease specific quality of life following an acute COPD exacerbation. Clinical Investigations 2002; 121: 688–696.

19.

19 Miravitles M Ferrer M Pont A Zalacain R Alvarez-Sala JL . Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax 2004; 59: 387–395.

20.